We’d like to introduce you to the fellow above, whose name is Jae. When asked what area of study she specializes in, she only ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

Funding for a landmark health study, the Women's Health Initiative, was cut then reportedly restored, but researchers are ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

As of last week, Chris Klomp is in charge of the Center for Medicare. Unlike predecessors, he’s not a policy wonk. Klomp was ...

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...

Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...

In a 7-2 decision, the Supreme Court agreed with HHS's narrow interpretation of how to pay hospitals for treating low-income patients.

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

If the law is struck down or any ambiguity left surrounding its validity, coverage of and access to preventive care like PrEP ...

BridgeBio’s recently approved heart drug blew past expectations as the biotech continues to see a strong demand for its first major commercial product.

For the second consecutive year, the pharma industry saw its reputation dip among patient advocacy groups, largely due to ...